The Trendlines Group (SGX:42T) said its board and audit committee approved investments by related companies of Librae Holdings in its portfolio firms, according to a Friday filing on the Singapore Exchange.
The Librae-related companies, ultimately owned by a trust benefiting British businessman Vincent Tchenguiz, will invest a total of $2.2 million across four Trendlines-backed firms, while Trendlines itself will contribute $850,000.
Trendlines said the investments include $350,000 in Arcuro Medical, $600,000 in IBI AG, $600,000 in Ceretrieve, and $600,000 in Celleste Bio.
The funding will be structured as either share purchase agreements or Simple Agreements for Future Equity (SAFE).
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。